KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,484,770 | -22.1% | 38,351 | -0.0% | 0.06% | -15.6% |
| Q2 2023 | $8,320,317 | +19.4% | 38,369 | +0.0% | 0.08% | +11.6% |
| Q1 2023 | $6,966,075 | -7.2% | 38,351 | +0.4% | 0.07% | -11.5% |
| Q4 2022 | $7,508,462 | -12.6% | 38,211 | 0.0% | 0.08% | -20.4% |
| Q3 2022 | $8,595,000 | +77.8% | 38,211 | 0.0% | 0.10% | +88.5% |
| Q2 2022 | $4,834,000 | -0.2% | 38,211 | 0.0% | 0.05% | +15.6% |
| Q1 2022 | $4,845,000 | -3.2% | 38,211 | 0.0% | 0.04% | -2.2% |
| Q4 2021 | $5,006,000 | +7.1% | 38,211 | 0.0% | 0.05% | -2.1% |
| Q3 2021 | $4,674,000 | +7.3% | 38,211 | 0.0% | 0.05% | +6.8% |
| Q2 2021 | $4,356,000 | -5.2% | 38,211 | 0.0% | 0.04% | -20.0% |
| Q1 2021 | $4,594,000 | +18.3% | 38,211 | 0.0% | 0.06% | +7.8% |
| Q4 2020 | $3,882,000 | +31.4% | 38,211 | 0.0% | 0.05% | +18.6% |
| Q3 2020 | $2,954,000 | – | 38,211 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |